FN1 and neoplasm: designed and constructed a Fn‐mimicking nanomedicine (Colistin‐LipoFM) which selectively killed Fn colonizing tumor cells while successfully restoring responsiveness to ICB therapy.[27] These pioneering studies have demonstrated the significant advantage of targeting and eliminating intra‐tumor microbiota in treating bacteria‐infiltrated primary tumors.